vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Summit Hotel Properties, Inc. (INN). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $185.1M, roughly 1.0× Summit Hotel Properties, Inc.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -5.6%, a 6.6% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 0.3%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -2.3%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
The Ritz-Carlton Hotel Company, LLC is an American multinational company that operates the luxury hotel chain known as The Ritz-Carlton. The company has 108 luxury hotels and resorts in 30 countries and territories with 29,158 rooms, in addition to 46 hotels with 8,755 rooms planned for the future.
FOLD vs INN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $185.1M |
| Net Profit | $1.7M | $-10.4M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 7.6% |
| Net Margin | 0.9% | -5.6% |
| Revenue YoY | 23.7% | 0.3% |
| Net Profit YoY | -88.5% | -122.9% |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $185.1M | ||
| Q4 25 | $185.2M | $175.0M | ||
| Q3 25 | $169.1M | $177.1M | ||
| Q2 25 | $154.7M | $192.9M | ||
| Q1 25 | $125.2M | $184.5M | ||
| Q4 24 | $149.7M | $172.9M | ||
| Q3 24 | $141.5M | $176.8M | ||
| Q2 24 | $126.7M | $193.9M |
| Q1 26 | — | $-10.4M | ||
| Q4 25 | $1.7M | $-2.6M | ||
| Q3 25 | $17.3M | $-11.8M | ||
| Q2 25 | $-24.4M | $2.0M | ||
| Q1 25 | $-21.7M | $623.0K | ||
| Q4 24 | $14.7M | $916.0K | ||
| Q3 24 | $-6.7M | $-3.6M | ||
| Q2 24 | $-15.7M | $38.7M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | 7.6% | ||
| Q4 25 | 8.6% | 8.3% | ||
| Q3 25 | 20.3% | 4.8% | ||
| Q2 25 | -6.1% | 11.8% | ||
| Q1 25 | -6.3% | 10.7% | ||
| Q4 24 | 10.7% | 4.6% | ||
| Q3 24 | 15.3% | 8.9% | ||
| Q2 24 | 11.8% | 29.0% |
| Q1 26 | — | -5.6% | ||
| Q4 25 | 0.9% | -1.5% | ||
| Q3 25 | 10.2% | -6.6% | ||
| Q2 25 | -15.8% | 1.1% | ||
| Q1 25 | -17.3% | 0.3% | ||
| Q4 24 | 9.8% | 0.5% | ||
| Q3 24 | -4.8% | -2.0% | ||
| Q2 24 | -12.4% | 20.0% |
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.05 | ||
| Q3 25 | $0.06 | $-0.11 | ||
| Q2 25 | $-0.08 | $-0.02 | ||
| Q1 25 | $-0.07 | $-0.04 | ||
| Q4 24 | $0.05 | $0.05 | ||
| Q3 24 | $-0.02 | $-0.04 | ||
| Q2 24 | $-0.05 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $44.8M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $840.4M |
| Total Assets | $949.9M | $2.8B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $44.8M | ||
| Q4 25 | $293.5M | $36.1M | ||
| Q3 25 | $263.8M | $41.1M | ||
| Q2 25 | $231.0M | $39.5M | ||
| Q1 25 | $250.6M | $48.2M | ||
| Q4 24 | $249.9M | $40.6M | ||
| Q3 24 | $249.8M | $51.7M | ||
| Q2 24 | $260.1M | $45.9M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | $1.4B | ||
| Q3 25 | $392.0M | $1.4B | ||
| Q2 25 | $391.3M | $1.4B | ||
| Q1 25 | $390.7M | $1.4B | ||
| Q4 24 | $390.1M | $1.4B | ||
| Q3 24 | $389.5M | $1.3B | ||
| Q2 24 | $388.9M | $1.3B |
| Q1 26 | — | $840.4M | ||
| Q4 25 | $274.2M | $862.2M | ||
| Q3 25 | $230.4M | $875.8M | ||
| Q2 25 | $204.3M | $895.1M | ||
| Q1 25 | $193.6M | $920.4M | ||
| Q4 24 | $194.0M | $909.5M | ||
| Q3 24 | $178.8M | $911.4M | ||
| Q2 24 | $132.5M | $931.9M |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $949.9M | $2.8B | ||
| Q3 25 | $868.8M | $2.8B | ||
| Q2 25 | $815.3M | $2.9B | ||
| Q1 25 | $789.8M | $2.9B | ||
| Q4 24 | $785.0M | $2.9B | ||
| Q3 24 | $786.6M | $2.8B | ||
| Q2 24 | $749.5M | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 1.62× | ||
| Q3 25 | 1.70× | 1.62× | ||
| Q2 25 | 1.92× | 1.59× | ||
| Q1 25 | 2.02× | 1.54× | ||
| Q4 24 | 2.01× | 1.54× | ||
| Q3 24 | 2.18× | 1.47× | ||
| Q2 24 | 2.93× | 1.44× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | 29.7% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $149.0M | ||
| Q3 25 | $35.7M | $45.8M | ||
| Q2 25 | $-26.5M | $48.8M | ||
| Q1 25 | $7.8M | $25.9M | ||
| Q4 24 | $-3.9M | $166.3M | ||
| Q3 24 | $-23.0M | $55.7M | ||
| Q2 24 | $22.7M | $50.3M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $73.6M | ||
| Q3 25 | $35.3M | $24.0M | ||
| Q2 25 | $-28.9M | $30.0M | ||
| Q1 25 | $7.5M | $10.1M | ||
| Q4 24 | $-4.2M | $77.0M | ||
| Q3 24 | $-23.3M | $33.1M | ||
| Q2 24 | $21.6M | $29.4M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 42.0% | ||
| Q3 25 | 20.9% | 13.5% | ||
| Q2 25 | -18.7% | 15.5% | ||
| Q1 25 | 6.0% | 5.5% | ||
| Q4 24 | -2.8% | 44.5% | ||
| Q3 24 | -16.5% | 18.7% | ||
| Q2 24 | 17.0% | 15.2% |
| Q1 26 | — | 29.7% | ||
| Q4 25 | 0.2% | 43.1% | ||
| Q3 25 | 0.2% | 12.3% | ||
| Q2 25 | 1.6% | 9.8% | ||
| Q1 25 | 0.2% | 8.5% | ||
| Q4 24 | 0.2% | 51.6% | ||
| Q3 24 | 0.3% | 12.7% | ||
| Q2 24 | 0.9% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | 23.97× | ||
| Q1 25 | — | 41.49× | ||
| Q4 24 | -0.27× | 181.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
INN
| Pro forma room revenue | $162.1M | 88% |
| Pro forma other hotel operations revenue | $22.4M | 12% |
